Effect of time of preparation on pentagastrin-induced symptom, endocrine and cardiovascular responses

Psychiatry Research

Volumn 158, Issue 2, 2008, Pages 141-146

  Khan, Samir ^a   Briggs, Hedieh ^a   Abelson, James Lawrence ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anxiety; CCK; Cortisol; HPA; Panic; Pentagastrin

Indexed keywords

CHOLECYSTOKININ; HYDROCORTISONE; PENTAGASTRIN;

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PANIC; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; ANXIETY; CHOLECYSTOKININ; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL AGENTS; HEART RATE; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MALE; PANIC DISORDER; PENTAGASTRIN; TIME FACTORS;

EID: 39649111110     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.10.020     Document Type: Article

References (14)

1. Abelson J.L., and Liberzon I. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology 21 (1999) 485-494
2. Abelson J.L., and Nesse R.M. Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular responses. Biological Psychiatry 36 (1994) 84-96
3. Abelson J.L., Liberzon I., Young E.A., and Khan S. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Archives of General Psychiatry 62 (2005) 668-675
4. Bradwejn J., and Koszycki D. Cholecystokinin and panic disorder: past and future clinical research strategies. Scandinavian Journal of Clinical and Laboratory Investigations. Supplement 234 (2001) 19-27
5. Bradwejn J., Koszycki D., and Meterissian G. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Canadian Journal of Psychiatry 35 (1990) 83-85
6. Charney D.S., Heninger G.R., and Jatlow P.I. Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry 42 (1985) 233-243
7. Hollander E., Liebowitz M.R., Gorman J.M., Cohen B., Fyer A., and Klein D.F. Cortisol and sodium lactate-induced panic. Archives of General Psychiatry 46 (1989) 135-140
8. Khan S., Liberzon I., and Abelson J.L. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin. Psychiatry Research 126 (2004) 189-195
9. Khan S., Liberzon I., and Abelson J.L. Effects of propranolol on symptom and endocrine responses to pentagastrin. Psychoneuroendocrinology 29 (2004) 1163-1171
10. Koszycki D., Zacharko R.M., Le Melledo J.M., and Bradwejn J. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depression and Anxiety 8 (1998) 1-7
11. Peskind E.R., Jensen C.F., Pascualy M., Tsuang D., Cowley D., Martin D.C., Wilkinson C.W., and Raskind M.A. Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder. Biological Psychiatry 44 (1998) 1007-1016
12. Rotzinger S., and Vaccarino F.J. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models. Journal of Psychiatry and Neuroscience 28 (2003) 171-181
13. Sinha S.S., Coplan J.D., Pine D.S., Martinez J.A., Klein D.F., and Gorman J.M. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation. Psychiatry Research 86 (1999) 93-98
14. Zwanzger P., Eser D., Padberg F., Baghai T.C., Schule C., Rotzer F., Ella R., Moller H.J., and Rupprecht R. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers. Depression and Anxiety 18 (2003) 140-143